MARATTO
UniversitiesCharles Agyemang
Active, last published 2026

In diabetes, cardiovascular risks, and lipoproteins

Charles
Agyemang

ScholarScholar

Research focused on Diabetes, Cardiovascular Risks, and Lipoproteins and adjacent fields.

Johns Hopkins University
Claim Your Profile

66

H-index

16.0k

Citations

Charles has not officially claimed their profile. If you are Charles, claim it free.

Claim Your Profile
Pioneer

Pioneer

LOCKED

Pathfinder

Pathfinder

LOCKED

Scholar

Scholar

EARNED

Innovator

Innovator

LOCKED

Inventor

Inventor

LOCKED

Catalyst

Catalyst

LOCKED

Expert

Expert

UPGRADE

01 · About the work

What I study

harles Agyemang is a researcher working on Diabetes, Cardiovascular Risks, and Lipoproteins. A fuller summary will appear once they update their profile.

02 · Reach

Publication output and reach

Charles's work has been cited 16,035 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.

03 · Research focus

Topics

Diabetes, Cardiovascular Risks, and Lipoproteins×99Global Public Health Policies and Epidemiology×96Blood Pressure and Hypertension Studies×94Migration, Health and Trauma×87Health disparities and outcomes×53
04 · Where I am

Affiliations

Affiliation on published researchJohns Hopkins UniversityDrawn from the institution listed on this researcher’s published work.

Research themes (UN SDGs)

05 · Selected work

Recent publications

16 works

Expert Academic Profiles go further

Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.

Explore Expert

Are you Charles?

Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.

African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.

Claim Your Profile

Free to claim · takes a minute to verify it’s you